Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells.

Fillebeen C, Pantopoulos K.

J Hepatol. 2010 Dec;53(6):995-9. doi: 10.1016/j.jhep.2010.04.044. Epub 2010 Aug 1.

PMID:
20813419
2.

Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.

Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, Hentze MW, Koromilas AE, Pantopoulos K.

J Biol Chem. 2005 Mar 11;280(10):9049-57. Epub 2005 Jan 6.

3.

ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.

Abe H, Imamura M, Hiraga N, Tsuge M, Mitsui F, Kawaoka T, Takahashi S, Ochi H, Maekawa T, Hayes CN, Tateno C, Yoshizato K, Murakami S, Yamashita N, Matsuhira T, Asai K, Chayama K.

J Hepatol. 2011 Jul;55(1):11-8. doi: 10.1016/j.jhep.2010.10.017. Epub 2010 Nov 29.

PMID:
21145867
4.

Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.

Fillebeen C, Muckenthaler M, Andriopoulos B, Bisaillon M, Mounir Z, Hentze MW, Koromilas AE, Pantopoulos K.

J Hepatol. 2007 Jul;47(1):12-22. Epub 2007 Mar 2.

PMID:
17399844
5.

Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes.

Bartolomei G, Cevik RE, Marcello A.

J Gen Virol. 2011 Sep;92(Pt 9):2072-81. doi: 10.1099/vir.0.032706-0. Epub 2011 May 18.

PMID:
21593278
6.

Replication studies using genotype 1a subgenomic hepatitis C virus replicons.

Gu B, Gates AT, Isken O, Behrens SE, Sarisky RT.

J Virol. 2003 May;77(9):5352-9.

7.

Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.

Horscroft N, Bellows D, Ansari I, Lai VC, Dempsey S, Liang D, Donis R, Zhong W, Hong Z.

J Virol. 2005 Mar;79(5):2788-96.

8.

Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.

Young KC, Lindsay KL, Lee KJ, Liu WC, He JW, Milstein SL, Lai MM.

Hepatology. 2003 Oct;38(4):869-78.

PMID:
14512874
9.

Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.

Ravikumar YS, Ray U, Nandhitha M, Perween A, Raja Naika H, Khanna N, Das S.

Virus Res. 2011 Jun;158(1-2):89-97. doi: 10.1016/j.virusres.2011.03.014. Epub 2011 Mar 31.

PMID:
21440018
10.

Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.

Ohara E, Hiraga N, Imamura M, Iwao E, Kamiya N, Yamada I, Kono T, Onishi M, Hirata D, Mitsui F, Kawaoka T, Tsuge M, Takahashi S, Abe H, Hayes CN, Ochi H, Tateno C, Yoshizato K, Tanaka S, Chayama K.

J Hepatol. 2011 May;54(5):872-8. doi: 10.1016/j.jhep.2010.08.033. Epub 2010 Oct 26.

PMID:
21145818
11.

Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.

Sarrazin C, Mihm U, Herrmann E, Welsch C, Albrecht M, Sarrazin U, Traver S, Lengauer T, Zeuzem S.

J Infect Dis. 2005 Nov 15;192(10):1710-9. Epub 2005 Oct 14.

PMID:
16235168
12.

Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.

Chang KO, George DW.

J Virol. 2007 Sep;81(18):9633-40. Epub 2007 Jul 3.

13.

Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.

Kumar D, Chaudhury I, Kar P, Das RH.

J Gastroenterol Hepatol. 2009 May;24(5):872-8. doi: 10.1111/j.1440-1746.2008.05717.x. Epub 2009 Feb 9.

PMID:
19220662
14.

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.

Zhu H, Butera M, Nelson DR, Liu C.

Virol J. 2005 Sep 7;2:80.

15.

The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.

Klumpp K, Lévêque V, Le Pogam S, Ma H, Jiang WR, Kang H, Granycome C, Singer M, Laxton C, Hang JQ, Sarma K, Smith DB, Heindl D, Hobbs CJ, Merrett JH, Symons J, Cammack N, Martin JA, Devos R, Nájera I.

J Biol Chem. 2006 Feb 17;281(7):3793-9. Epub 2005 Nov 29.

16.

Specific inhibition of hepatitis C virus replication by cyclosporin A.

Nakagawa M, Sakamoto N, Enomoto N, Tanabe Y, Kanazawa N, Koyama T, Kurosaki M, Maekawa S, Yamashiro T, Chen CH, Itsui Y, Kakinuma S, Watanabe M.

Biochem Biophys Res Commun. 2004 Jan 2;313(1):42-7.

PMID:
14672695
17.

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.

Bachmetov L, Gal-Tanamy M, Shapira A, Vorobeychik M, Giterman-Galam T, Sathiyamoorthy P, Golan-Goldhirsh A, Benhar I, Tur-Kaspa R, Zemel R.

J Viral Hepat. 2012 Feb;19(2):e81-8. doi: 10.1111/j.1365-2893.2011.01507.x. Epub 2011 Aug 16.

PMID:
22239530
18.

Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin.

Paeshuyse J, Coelmont L, Vliegen I, Van hemel J, Vandenkerckhove J, Peys E, Sas B, De Clercq E, Neyts J.

Biochem Biophys Res Commun. 2006 Sep 15;348(1):139-44. Epub 2006 Jul 13.

PMID:
16875675
19.

Zinc is a negative regulator of hepatitis C virus RNA replication.

Yuasa K, Naganuma A, Sato K, Ikeda M, Kato N, Takagi H, Mori M.

Liver Int. 2006 Nov;26(9):1111-8.

PMID:
17032412
20.

Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives.

Salim MT, Aoyama H, Sugita K, Watashi K, Wakita T, Hamasaki T, Okamoto M, Urata Y, Hashimoto Y, Baba M.

Biochem Biophys Res Commun. 2011 Dec 2;415(4):714-9. doi: 10.1016/j.bbrc.2011.10.153. Epub 2011 Nov 9.

PMID:
22085716

Supplemental Content

Support Center